Smoothspas P 50mg/325mg Tablet
By Smoothspas P
Rx
10 Tablet in a Strip

Composition
Mefenamic Acid(50mg) + Paracetamol(325mg)

Manufacturer - P R G Pharma Pvt Ltd
305,3rd Floor, Progressive House, Rohit Kunj, Pitampura,Delhi-110034 , India

Expires on or after
October, 2025

liver
Smoothspas P 50mg/325mg Tablet should be used carefully in patients with liver disease. It may require a dose adjustment, so it is important to consult your doctor before using this medication. However, Smoothspas P 50mg/325mg Tablet is not advised for individuals with severe liver disease or active liver disease. Make sure to seek medical advice to ensure the proper and safe use of this medication.

kidney
Smoothspas P 50mg/325mg Tablet should be used cautiously in patients with kidney disease. Dose adjustment may be necessary. Avoid using in severe kidney disease. Consult your doctor for proper guidance.

alcohol
It is not safe to drink alcohol while taking Smoothspas P 50mg/325mg Tablet.

driving
Smoothspas P 50mg/325mg Tablet can reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Smoothspas P 50mg/325mg Tablet may not be safe for use during pregnancy. Limited human studies suggest potential harm to the developing baby based on animal studies. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before using during pregnancy.

breastfeeding
Smoothspas P 50mg/325mg Tablet is considered safe to use during breastfeeding. Studies indicate that the drug does not pass into breastmilk in significant amounts, posing no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹39.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025